Black Americans are more likely to get pancreatic cancer than any other racial or ethnic group, according the National Cancer ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Pancreatic cancer is one of the most lethal cancers, with only about 12% of patients surviving five years after diagnosis. A ...

A new study from Cedars-Sinai Cancer has revealed that doctors often misjudge the stage of early pancreatic cancer, with ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Data from a Phase I trial of Avmapki Fakzynja also supports the regimen's tolerability and suggests its potential activity in ...

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Pancreatic Cancer Action has appointed Anthony Cummings as its new CEO. Cummings' experience spans over 25 years in the charitable sector, across a range of organisations. He previously worked as ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...